News of Note—Attune Medical bags $10M; Abbott debuts neurostimulator for complex regional pain syndrome


> Attune Medical raised $10 million in series C financing for its esophageal temperature management devices. Release

> Abbott launched a new neurostimulator, the Proclaim DRG system, which treats complex regional pain syndrome of the lower limbs by stimulating the dorsal root ganglion. Release

> One Drop unveiled its diabetes management program, based on its wireless blood glucose monitoring system, which it plans to launch in 2018. Release | Read more about One Drop


Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

Suggested Articles

By employing heart rate signals, physical activity and sleep quality, common Fitbit trackers may be able to predict the spread of the flu.

Nanox has raised $26 million to help fuel the development and commercialization of its "Star Trek"-inspired digital X-ray bed.

Oncology is clearly a major medical and societal issue, but one that sees too much focus from biopharmas at the expense of other killers.